These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


470 related items for PubMed ID: 6335179

  • 21. [Circulating immune complexes in a population of subjects seropositive for rheumatoid factor].
    Aureli G, Battista V, Bianchi L, Bolzonetti A, Cipriani A, Carnevali GF, Caschera F, Caputo B, Danieli G, Corvetta A.
    Boll Ist Sieroter Milan; 1982; 61(5):367-74. PubMed ID: 6985415
    [Abstract] [Full Text] [Related]

  • 22. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U, Heinz HP, Loos M.
    J Immunol Methods; 1987 Sep 24; 102(2):149-56. PubMed ID: 2443573
    [Abstract] [Full Text] [Related]

  • 23. Circulating immune complexes and rheumatoid arthritis.
    Faaber P, Rijke Schilder TP, Capel PJ, Koene RA.
    J Rheumatol; 1985 Oct 24; 12(5):849-53. PubMed ID: 3878875
    [Abstract] [Full Text] [Related]

  • 24. Isolation and characterization of circulating immune complexes in patients with rheumatoid arthritis.
    Perego R, Vezzoli S, Manfredi W, Bigi G, Procaccia S.
    Boll Ist Sieroter Milan; 1983 Nov 30; 62(5):462-8. PubMed ID: 6608359
    [Abstract] [Full Text] [Related]

  • 25. Characterization of C1q by monoclonal antibodies.
    Heinz HP, Loos M.
    Behring Inst Mitt; 1984 Nov 30; (76):42-58. PubMed ID: 6335397
    [Abstract] [Full Text] [Related]

  • 26. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W, Hiepe F, Courault K, Porstmann B, Apostoloff E.
    Biomed Biochim Acta; 1983 Nov 30; 42(7-8):1027-35. PubMed ID: 6360166
    [Abstract] [Full Text] [Related]

  • 27. The effect of a protein meal on three fluid-phase assays for circulating immune complexes.
    Elkon KB, Lanham JG, Dash AC, Hughes GR.
    Clin Exp Immunol; 1981 Aug 30; 45(2):279-82. PubMed ID: 6976243
    [Abstract] [Full Text] [Related]

  • 28. Chronic liver disease: the detection and characterization of circulating immune complexes.
    Brown SE, Steward MW, Viola L, Howard CR, Murray-Lyon IM.
    Immunology; 1983 Aug 30; 49(4):673-83. PubMed ID: 6307866
    [Abstract] [Full Text] [Related]

  • 29. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
    Belozerov AP.
    Lab Delo; 1989 Aug 30; (3):24-6. PubMed ID: 2469833
    [Abstract] [Full Text] [Related]

  • 30. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J, Wener MH, Mannik M.
    J Rheumatol; 2002 Jan 30; 29(1):84-9. PubMed ID: 11824976
    [Abstract] [Full Text] [Related]

  • 31. C1q binding activity in the sera of patients with chronic lung diseases.
    Cooper KM, Moore M, Hilton AM.
    Clin Exp Immunol; 1981 Jul 30; 45(1):18-28. PubMed ID: 6975678
    [Abstract] [Full Text] [Related]

  • 32. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G, Schouten J, Cats A, Daha MR.
    Immunology; 1985 Jul 30; 55(3):555-64. PubMed ID: 4018839
    [Abstract] [Full Text] [Related]

  • 33. Differential precipitation of the Clq subcomponent of the first complement component (C1) by polyethylene glycol from normal human serum and sera of patients with collagen diseases.
    Van Dijk H, Van Voorst J, Jankowski IG, Imhof JW, Kerckhaert JA.
    Clin Exp Immunol; 1984 Aug 30; 57(2):495-501. PubMed ID: 6432386
    [Abstract] [Full Text] [Related]

  • 34. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
    Krieger G, Bause I, Kneba M, Kehl A, Nagel GA.
    J Clin Lab Immunol; 1984 Jun 30; 14(2):87-92. PubMed ID: 6611419
    [Abstract] [Full Text] [Related]

  • 35. Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor.
    Mackel SE, Tappeiner G, Brumfield H, Jordan RE.
    J Clin Invest; 1979 Dec 30; 64(6):1652-60. PubMed ID: 500831
    [Abstract] [Full Text] [Related]

  • 36. [Use of solid-phase Clq-ELISA for detecting circulating immune complexes in human diseases].
    Aleshkin VA, Nasonov EL, Eremeeva MV, Kobylianskiĭ AG.
    Ter Arkh; 1989 Dec 30; 61(6):113-6. PubMed ID: 2477907
    [Abstract] [Full Text] [Related]

  • 37. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC, Bey RF, Loken KI.
    Am J Vet Res; 1988 Jun 30; 49(6):865-9. PubMed ID: 3135770
    [Abstract] [Full Text] [Related]

  • 38. The detection of circulating immune complexes containing immunoglobulin G.
    Valentijn RM, van Es LA, Westedt ML, Daha MR.
    J Clin Lab Immunol; 1984 Jun 30; 14(2):73-9. PubMed ID: 6748049
    [Abstract] [Full Text] [Related]

  • 39. Stimulation of human neutrophil chemiluminescence by soluble immune complexes and antibodies to neutrophils.
    Starkebaum G, Stevens DL, Henry C, Gavin SE.
    J Lab Clin Med; 1981 Aug 30; 98(2):280-91. PubMed ID: 6972984
    [Abstract] [Full Text] [Related]

  • 40. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
    Bratt T, Ohlson S.
    J Clin Lab Immunol; 1988 Dec 30; 27(4):191-5. PubMed ID: 3266946
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 24.